# US 2019/0167851 A1 · Orthopedic implant for sustained drug release

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167851 A1
- Document ID: US20190167851A1
- Status: Published application
- Kind: A1
- Application number: 15/973,820
- Filed: 2018-05-08
- Published: 2019-06-06
- Earliest claimed: 2017-12-04
- Assignees: Duke University
- Applicants: Duke University
- Inventors: Kenneth A. Gall; Thorsten M. Seyler; Brian Allen; Sarah Dicker; Catherine Oliver
- Web page: https://patentgrep.com/patent/US20190167851A1

## CPC

- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61F 2/30771: {applied in original prostheses, e.g. holes or grooves}
- A61F 2/38: for elbows or knees
- A61F 2/3859: {Femoral components}
- A61F 2/389: {Tibial components (A61F2/3868 takes precedence)}
- A61L 27/025: {Other specific inorganic materials not covered by A61L27/04 - A61L27/12}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61F 2002/30062: {(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive}
- A61F 2002/30235: {tubular, e.g. sleeves}
- A61F 2002/30331: {made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit}
- A61F 2002/3068: {the pharmaceutical product being in a reservoir}
- A61F 2002/30784: {Plurality of holes}
- A61F 2002/30878: {with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts}
- A61F 2002/3092: {having an open-celled or open-pored structure}
- A61L 2300/406: Antibiotics
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A method includes forming a mixture including a therapeutic agent and a solid delivery medium, injecting the mixture into a reservoir within an orthopedic implant body, and storing the injected mixture in the reservoir.

## Claims

### Claim 1

A method comprising:
forming a mixture including a therapeutic agent and a solid delivery medium;
injecting the mixture into a reservoir within an orthopedic implant body having elution pores; and
storing the injected mixture in the reservoir.

### Claim 2 (depends on 1)

A method as defined in claim 1, wherein forming the mixture comprises mixing the therapeutic agent and the solid delivery medium with water.

### Claim 3 (depends on 2)

A method as defined in claim 2, wherein storing the injected mixture comprises solidifying the injected mixture in the reservoir.

### Claim 4 (depends on 3)

A method as defined in claim 3, further comprising the step of covering the elution pores as the injected mixture solidifies in the reservoir.

### Claim 5 (depends on 1)

A method as defined in claim 1, wherein the solid delivery medium is biodegradable under the influence of synovial fluid.

### Claim 6 (depends on 5)

A method as defined in claim 5, wherein the solid delivery medium comprises a solid binder.

### Claim 7 (depends on 6)

A method as defined in claim 6, wherein the solid binder comprises a powder.

### Claim 8 (depends on 7)

A method as defined in claim 7, wherein the powder comprises calcium sulfate powder.

### Claim 9

A method comprising:
forming a mixture of a therapeutic agent, a solid delivery medium that is biodegradable under the influence of synovial fluid, and water;
inserting the mixture into a reservoir within an orthopedic implant body having elution pores; and
storing the inserted mixture in the reservoir.

### Claim 10 (depends on 9)

A method as defined in claim 9, wherein inserting the mixture comprises injecting the mixture.

### Claim 11 (depends on 9)

A method as defined in claim 9 wherein storing the inserted mixture comprises solidifying the inserted mixture in the reservoir.

### Claim 12 (depends on 11)

A method as defined in claim 11, further comprising the step of covering the elution pores as the injected mixture solidifies in the reservoir.

### Claim 13 (depends on 9)

A method as defined in claim 9 wherein the solid delivery medium comprises a solid binder.

### Claim 14 (depends on 13)

A method as defined in claim 13 wherein the solid binder comprises a powder.

### Claim 15 (depends on 14)

A method as defined in claim 14 wherein the powder comprises calcium sulfate powder.

### Claim 16

A method comprising:
forming a paste comprising a mixture of a therapeutic agent, a solid delivery medium that is biodegradable under the influence of synovial fluid, and water;
injecting the paste into a reservoir within an orthopedic implant body having elution pores;
solidifying the injected paste in the reservoir; and
covering the elution pores as the injected paste solidifies in the reservoir.

### Claim 17 (depends on 16)

A method as defined in claim 16 wherein the solid delivery medium comprises a solid binder.

### Claim 18 (depends on 17)

A method as defined in claim 17 wherein the solid binder comprises a powder.

### Claim 19 (depends on 18)

A method as defined in claim 18 wherein the powder comprises calcium sulfate powder.

### Claim 20 (depends on 16)

A method as defined in claim 16 wherein the therapeutic agent comprises an antibiotic.
